Search Results for 'treatment psa'
treatment psa published presentations and documents on DocSlides.
Psoriatic Arthritis Introduction to PsA
by phoebe-click
Key Cell Types and Activated Pathways in Psoriati...
Updates for Dermatologists and Rheumatologists on PsA Management: Role of IL-17 Inhibitors
by marina-yarberry
IL-17 Inhibitors in the Management of Psoriatic D...
In biochemical recurrence after curative treatment of prost
by lindy-dunigan
1- has a detection rate of 10-20% when PSA: 1-2 n...
Faculty Kori Dewing, ANP-BC, DNP, ARNP
by briana-ranney
Rheumatology Nurse Practitioner. University of Wa...
 B. BEN SALAH, M. AMOR, M. MAATOUK, R.BEN SOUSSIA, H. KTATA, M.A. JELLALI, W. MNARI, A. ZRIG, W.
by laobeast
P. ersistent sciatic artery: report of a case and ...
Emerging Treatment Strategies for Psoriatic Arthritis:
by violet
Focus on IL-23 Inhibitors. Psoriatic Arthritis. Ps...
Prostate cancer: To screen or not to screen
by evans
–. To treat . or not to treat. Dr Oliver Klein �...
mCSPC Patient detailing ADT: androgen deprivation therapy; BPH: benign prostatic hyperplasia; DRE:
by olivia
Extraprostatic. . Exteneion. ; MRI: magnetic reso...
Prostate Cancer Screening and Early Prostate Cancer Management
by hadly
Dr Marie-Pier St-Laurent, MD, FRCSC. Urologic-Onco...
How do you know when to enter Active Surveillance and when to leave?
by bency
Kirsten Greene, MD, MS, FACS. Paul Mellon Professo...
Prostate cancer isn’t colorblind
by stefany-barnette
Ruth Etzioni. Roman Gulati . Lurdes . inouE. Dham...
Prostate Cancer Screening in the Post-USPSTF Era
by lindy-dunigan
Alon Z. Weizer, MD, MS. Associate Professor of Ur...
Therapies for Clinically Localized Prostate Cancer
by fauna
Background A National Institutes of Health NIH pan...
NASPCC: ABCs of Androgen Deprivation Therapy (ADT)
by maisie
Jeanny B. Aragon-Ching, M.D., F.A.C.P.. Clinical P...
rostate cancer PC is the most common cancer and the leading cause of
by callie
279
in Mexico, PC prevalence and the consequent im...
Target trial emulation Causal inference from observational data
by cappi
Joy Shi, PhD. Instructor of Epidemiology. CAUSAL a...
No standardization of discharge process
by lane539
Patients were getting “lost to follow-up” (11%...